高级检索
当前位置: 首页 > 详情页

Impact of tils on the prognosis of IIIB colon cancer associated with c-FLIP

| 认领 | 导出 |

文献详情

资源类型:
机构: [1]Biotherapy Center, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China
出处:
ISSN:

关键词: C-FLIP L Colon cancer Prognosis Tumor-infiltrating lymphocytes

摘要:
Background: To find out useful tools to evaluate the prognosis of colon cancer, this study investigated how c-FLIP L and tumor-infiltrating lymphocytes (TILs) are correlated with the prognosis of patients with stage IIIB colon cancer. Methods: 180 cases of pathologically proven specimens with stage IIIB colon cancer (T3N1M0, AJCC, 7 th edition) were collected at Sun Yat-sen University Cancer Center. The expression of c-FLIP L and the density of TILs in tumor tissues were examined through immunohistochemical analysis. The correlation of c-FLIP L and TILs, with the prognosis of patients was analyzed. Results: C-FLIP L was correlated with an unfavorable overall survival (OS). The densities of CD8+ and CD45RO+ T cells were associated with a favorable OS, whereas Foxp3+ Treg cells were related to an unfavorable OS. However, the relationship between TILs and prognosis varied for two groups of patients that were divided according to c-FLIP L expression. In the group with high c-FLIP L expression, a high density of CD8+ and CD45RO+ T cells or a low density of Foxp3+ Treg cells was correlated with a short OS; In the group with low c-FLIP L expression, a high density of CD8+ and CD45RO+ T cells or a low density of Foxp3+ Treg cells was correlated with a long OS. Conclusion: This study revealed that the relationship between the density of TILs and the prognosis of colon cancer depended on the expression of c-FLIP L , indicating that the clinical outcome of immune response depended on not only the subtypes of TILs but also the genetic background of cancer cells. © 2017, E-Century Publishing Corporation. All rights reserved.

基金:
语种:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 4 区 医学
小类 | 4 区 医学:研究与实验
最新[2023]版:
第一作者:
第一作者机构: [1]Biotherapy Center, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:43370 今日访问量:0 总访问量:3120 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号